Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Novo Nordisk must face US shareholder lawsuit over CagriSema clinical trial

Summary by WTVB
July 28 (Reuters) - A U.S. judge said on Tuesday that Novo Nordisk ​must face part ‌of a lawsuit accusing it of defrauding shareholders about a clinical trial for its ‌weight ​loss and diabetes ⁠treatment CagriSema. Investors in ⁠Novo Nordisk's America...

2 Articles

PharmaphorumPharmaphorum
Center

US judge says Novo Nordisk must face lawsuit over CagriSema

A US judge has ruled that Novo Nordisk must face a lawsuit claiming it defrauded investors with misleading statements about a pivotal CagriSema study.

Read Full Article
WTVBWTVB
Center

Novo Nordisk must face US shareholder lawsuit over CagriSema clinical trial

July 28 (Reuters) - A U.S. judge said on Tuesday that Novo Nordisk ​must face part ‌of a lawsuit accusing it of defrauding shareholders about a clinical trial for its ‌weight ​loss and diabetes ⁠treatment CagriSema. Investors in ⁠Novo Nordisk's America...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WTVB broke the news on Tuesday, July 28, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Novo Nordisk icon

Novo Nordisk

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal